FDA OKs idelalisib

July 25, 2014

U.S. Food and Drug Administration (FDA) approved idelalisib (Zydelig tablets, Gilead Sciences, Inc.) for the treatment of patients with relapsed chronic lymphocytic leukemia, in combination with rituximab, for whom rituximab alone would be considered appropriate therapy due to other co-morbidities. Idelalisib is not yet approved by the TGA for marketing. The FDA has also approved Ruconest, the first recombinant C1- esterase inhibitor for the treatment of acute attacks in patients with hereditary angioedema. Ruconest is not yet approved for use in Australia.

The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jul 14
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jul 14

Other recent headlines

PD breaking news – Queensland pharmacies scope of practice pilot expanded
Wednesday | Apr 24 2024

Twenty-two additional health conditions added to Queensland pilot. The Pharmacy Guild of Australia Queensland Branch President…

Commbank to help navigate ownership
Wednesday | Apr 24 2024

A KEYNOTE session by CommBank Health will help attendees navigate the complexities of business ownership at the Pharmacy Careers Summit 2024 (PCS24).

Littleproud visits Orana Mall
Wednesday | Apr 24 2024

THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Wed 24 Apr 2024
PD for Tue 23 Apr 2024
PD for Mon 22 Apr 2024
PD for Fri 19 Apr 2024
PD for Thu 18 Apr 2024
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2018 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Name
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | FDA OKs idelalisib

FDA OKs idelalisib

Other recent headlines

PD breaking news – Queensland pharmacies scope of practice pilot expanded

Commbank to help navigate ownership

Littleproud visits Orana Mall

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES